244 related articles for article (PubMed ID: 24936253)
1. 12q24 locus association with type 1 diabetes: SH2B3 or ATXN2?
Auburger G; Gispert S; Lahut S; Omür O; Damrath E; Heck M; Başak N
World J Diabetes; 2014 Jun; 5(3):316-27. PubMed ID: 24936253
[TBL] [Abstract][Full Text] [Related]
2. ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population.
Lahut S; Ömür Ö; Uyan Ö; Ağım ZS; Özoğuz A; Parman Y; Deymeer F; Oflazer P; Koç F; Özçelik H; Auburger G; Başak AN
PLoS One; 2012; 7(8):e42956. PubMed ID: 22916186
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.
Ochoa E; Iriondo M; Bielsa A; Ruiz-Irastorza G; Estonba A; Zubiaga AM
PLoS One; 2013; 8(7):e67897. PubMed ID: 23844121
[TBL] [Abstract][Full Text] [Related]
4. Absence of SH2B3 mutation in nonobese diabetic mice.
Li YJ; Li XY; Guo XR; Li Y; Shen BF; Shi YC; Zhang JY
Genet Mol Res; 2012 May; 11(2):1266-71. PubMed ID: 22614355
[TBL] [Abstract][Full Text] [Related]
5. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
Sen NE; Canet-Pons J; Halbach MV; Arsovic A; Pilatus U; Chae WH; Kaya ZE; Seidel K; Rollmann E; Mittelbronn M; Meierhofer D; De Zeeuw CI; Bosman LWJ; Gispert S; Auburger G
Neurobiol Dis; 2019 Dec; 132():104559. PubMed ID: 31376479
[TBL] [Abstract][Full Text] [Related]
6. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
7. LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.
Wang W; Tang Y; Wang Y; Tascau L; Balcerek J; Tong W; Levine RL; Welch C; Tall AR; Wang N
Circ Res; 2016 Sep; 119(6):e91-e103. PubMed ID: 27430239
[TBL] [Abstract][Full Text] [Related]
8. Ataxin-2 repeat-length variation and neurodegeneration.
Ross OA; Rutherford NJ; Baker M; Soto-Ortolaza AI; Carrasquillo MM; DeJesus-Hernandez M; Adamson J; Li M; Volkening K; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Woodruff BK; Knopman DS; White CL; Van Gerpen JA; Meschia JF; Mackenzie IR; Boylan K; Boeve BF; Miller BL; Strong MJ; Uitti RJ; Younkin SG; Graff-Radford NR; Petersen RC; Wszolek ZK; Dickson DW; Rademakers R
Hum Mol Genet; 2011 Aug; 20(16):3207-12. PubMed ID: 21610160
[TBL] [Abstract][Full Text] [Related]
9. Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Halbach MV; Stehning T; Damrath E; Jendrach M; Şen NE; Başak AN; Auburger G
PLoS One; 2015; 10(3):e0121089. PubMed ID: 25790475
[TBL] [Abstract][Full Text] [Related]
10. [Sh2b3/Lnk family adaptor proteins in the regulation of lymphohematopoiesis].
Takaki S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):440-7. PubMed ID: 19122374
[TBL] [Abstract][Full Text] [Related]
11. Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels.
Sen NE; Drost J; Gispert S; Torres-Odio S; Damrath E; Klinkenberg M; Hamzeiy H; Akdal G; Güllüoğlu H; Başak AN; Auburger G
Neurobiol Dis; 2016 Dec; 96():115-126. PubMed ID: 27597528
[TBL] [Abstract][Full Text] [Related]
12. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.
Gispert S; Kurz A; Waibel S; Bauer P; Liepelt I; Geisen C; Gitler AD; Becker T; Weber M; Berg D; Andersen PM; Krüger R; Riess O; Ludolph AC; Auburger G
Neurobiol Dis; 2012 Jan; 45(1):356-61. PubMed ID: 21889984
[TBL] [Abstract][Full Text] [Related]
13. The Longevity-Associated SH2B3 (LNK) Genetic Variant: Selected Aging Phenotypes in 379,758 Subjects.
Kuo CL; Joaquim M; Kuchel GA; Ferrucci L; Harries LW; Pilling LC; Melzer D
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1656-1662. PubMed ID: 31428775
[TBL] [Abstract][Full Text] [Related]
14. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
15. Linking inflammation and hypertension via LNK/SH2B3.
Dale BL; Madhur MS
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
[TBL] [Abstract][Full Text] [Related]
17. Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs.
Mori T; Suzuki-Yamazaki N; Takaki S
Cell Rep; 2018 Aug; 24(7):1830-1841. PubMed ID: 30110639
[TBL] [Abstract][Full Text] [Related]
18. Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ-producing T cells.
Mori T; Iwasaki Y; Seki Y; Iseki M; Katayama H; Yamamoto K; Takatsu K; Takaki S
J Immunol; 2014 Aug; 193(4):1728-36. PubMed ID: 25024389
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate.
Fittschen M; Lastres-Becker I; Halbach MV; Damrath E; Gispert S; Azizov M; Walter M; Müller S; Auburger G
Neurogenetics; 2015 Jul; 16(3):181-92. PubMed ID: 25721894
[TBL] [Abstract][Full Text] [Related]
20. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F.
Koren-Michowitz M; Gery S; Tabayashi T; Lin D; Alvarez R; Nagler A; Koeffler HP
Br J Haematol; 2013 Jun; 161(6):811-20. PubMed ID: 23590807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
